(Q43491112)

24 November 2017

Coronavirus: need for a therapeutic approach (English)

1 reference

24 November 2017

1

1 reference

24 November 2017

Sylvie van der Werf

2

0 references

publication date

17 June 2013

1 reference

Lancet Infectious Diseases

24 November 2017

1 reference

24 November 2017

13

1 reference

24 November 2017

9

1 reference

24 November 2017

726-727

1 reference

Severe acute respiratory syndrome

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970153-1

7 January 2021

SARS: systematic review of treatment effects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970153-1

7 January 2021

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970153-1

7 January 2021

Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970153-1

7 January 2021

Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970153-1

7 January 2021

Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970153-1

7 January 2021

MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970153-1

7 January 2021

Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970153-1

7 January 2021

The newly emerged SARS-like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970153-1

7 January 2021

Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970153-1

7 January 2021

The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23782860

12 December 2020

inferred from PubMed ID database lookup

Family cluster of Middle East respiratory syndrome coronavirus infections

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23782860

12 December 2020

inferred from PubMed ID database lookup

Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23782860

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1016/S1473-3099(13)70153-1

1 reference

release_2z2zsxcfbzanxlzct5lnnxdjhu

24 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2z2zsxcfbzanxlzct5lnnxdjhu

24 November 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/2z2zsxcfbzanxlzct5lnnxdjhu

24 November 2022

mapped directly with Wikidata item

PubMed ID

23782860

1 reference

PubMed ID

23782860